Insider holders · CIK 0001645460
Cue Biopharma, Inc. · CUE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Shao-Lee LinChief Executive Officer | 705,995 | — | 705,995 | Aug 14, 2026 · 8:46 pm EDT | Form 4 |
| Cameron GrayDirector | 667,500 | — | 667,500 | Jun 14, 2018 · 5:34 pm EDT | Form 4 |
| Ronald D. Seidel IIIEVP, Head of R&D | 445,000 | — | 445,000 | Dec 27, 2017 · 1:40 pm EST | Form 3 |
| Rodolfo ChaparroEVP, Head of Immunology | 445,000 | — | 445,000 | Dec 27, 2017 · 1:30 pm EST | Form 3 |
| Sumita RayChief Legal Compliance Officer | 118,545 | — | 118,545 | Aug 17, 2026 · 6:22 pm EDT | Form 4 |
| Christopher A MarlettDirector | 9,000 | 89,602 | 98,602 | Jan 15, 2019 · 4:24 pm EST | Form 5 |
| Gary Alan SchumanInterim CFO | 66,750 | — | 66,750 | Dec 27, 2017 · 1:39 pm EST | Form 3 |
| Michael Vincent MeluzioVP, Prin. Accounting Officer | 48,961 | — | 48,961 | Aug 17, 2026 · 6:19 pm EDT | Form 4 |
| Daniel R PasseriCEO and President | 47,600 | — | 47,600 | Mar 8, 2019 · 4:17 pm EST | Form 4 |
| Dominique Christian BorieChief Medical Officer | 31,500 | — | 31,500 | Jul 15, 2026 · 6:59 pm EDT | Form 4 |
| Anthony DigiandomenicoDirector | 30,000 | — | 30,000 | Jan 4, 2019 · 6:21 pm EST | Form 4 |
| Pasha SarrafDirector | 29,195 | — | 29,195 | Aug 28, 2026 · 5:05 pm EDT | Form 4/A |
| James M AhlersChief Financial Officer | 25,500 | — | 25,500 | Aug 3, 2026 · 4:19 pm EDT | Form 4 |
| Viola Mong MeehanDirector | 21,800 | — | 21,800 | Jul 10, 2026 · 7:35 pm EDT | Form 4 |
| Daniel A. CamardoDirector | 21,800 | — | 21,800 | Jul 10, 2026 · 7:37 pm EDT | Form 4 |
| Pamela GarzoneDirector | 18,900 | — | 18,900 | Aug 28, 2026 · 5:04 pm EDT | Form 4/A |
| Anish SuriChief Scientific Officer | 2,000 | — | 2,000 | Mar 8, 2019 · 4:16 pm EST | Form 4 |
| Kenneth PientaChief Medical Officer | 2,000 | — | 2,000 | Jan 19, 2018 · 5:03 pm EST | Form 4 |
| Kerri-Ann MillarVP-Finance | 1,000 | — | 1,000 | Mar 8, 2019 · 4:09 pm EST | Form 4 |
| Bethany MancillaSVP and Chief Business Officer | 0 | — | 0 | Aug 2, 2018 · 5:12 pm EDT | Form 3 |
| Frank MorichDirector | 0 | — | 0 | Aug 2, 2018 · 5:08 pm EDT | Form 3 |
| Colin SandercockSVP, General Counsel and Sec | 0 | — | 0 | Dec 27, 2017 · 1:37 pm EST | Form 3 |
| Frederick W DriscollDirector | 0 | — | 0 | Jun 27, 2018 · 4:15 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.